<SEC-DOCUMENT>0001279569-19-001235.txt : 20190522
<SEC-HEADER>0001279569-19-001235.hdr.sgml : 20190522
<ACCEPTANCE-DATETIME>20190522141826
ACCESSION NUMBER:		0001279569-19-001235
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20190522
FILED AS OF DATE:		20190522
DATE AS OF CHANGE:		20190522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canopy Growth Corp
		CENTRAL INDEX KEY:			0001737927
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38496
		FILM NUMBER:		19845142

	BUSINESS ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
		BUSINESS PHONE:		855-558-9333

	MAIL ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>canopy6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 3pt">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"></p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 12pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>FORM&nbsp;6-K </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>REPORT OF FOREIGN ISSUER </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PURSUANT TO RULE 13a-16 OR 15d-16
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>OF THE SECURITIES EXCHANGE ACT OF
1934 </b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>For the month of May 2019</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Commission File No.&nbsp;001-38496</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 24pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Canopy Growth Corporation</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>1 Hershey Drive<br>
Smith Falls, Ontario<br>
K7A 0A8</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant files
or will file annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Form&nbsp;20-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font>
<font style="font-family: Times New Roman, Times, Serif">Form 40-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(1):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(7):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant by furnishing
the information contained in this Form&nbsp;is also thereby furnishing the information to the Commission pursuant to Rule&nbsp;12g3-2(b)&nbsp;under
the Securities Exchange Act of 1934.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font>
<font style="font-family: Times New Roman, Times, Serif">&nbsp;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 3pt; margin-bottom: 12pt"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>EXHIBIT INDEX </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 8%">&nbsp;</td>
    <td style="width: 2%">&nbsp;</td>
    <td style="width: 90%">&nbsp;</td></tr>
<tr>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Exhibit</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td>
    <td>&nbsp;</td>
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><b>Description</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr style="vertical-align: top">
    <td nowrap style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">99.1</A></FONT></td>
    <td><FONT STYLE="color: Black">&nbsp;</FONT></td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">Press
    Release - Canopy Growth acquires established skincare and well-being company This Works&reg;</A></FONT></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">1</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;&nbsp;</p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><u></u></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 50%">&nbsp;</td>
    <td style="width: 7%">&nbsp;</td>
    <td style="width: 43%">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canopy Growth Corporation</font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="vertical-align: bottom">
        <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">/s/ Bruce Linton</p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Linton</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</font></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Date: May 22, 2019</p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0.25in 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">2</p>




<p style="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED MAY 22, 2019
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_001.jpg" ALT="Logo: Canopy Growth Corporation (CNW Group|Canopy Growth Corporation)" STYLE="height: 65px; width: 99px"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth acquires established skincare
and well-being company This Works&reg;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">London-based firm will be an integral part
of Canopy Growth's entry into the natural wellness industry and further strengthens the Company's international presence</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SMITHS FALLS, ON and LONDON, May 22, 2019 /CNW/
-&nbsp;Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the &quot;Company&quot; or &quot;Canopy Growth&quot;) has finalized an
all-cash transaction to acquire This Works for a purchase price of &pound;43 million (CDN $73.8 million). Founded in 2004, This
Works has cemented itself as a global leader in natural skincare and sleep solutions with a devout customer base spanning 35 countries.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_002.jpg" ALT='"London-based This Works will be an integral part of Canopy Growth???s entry into the natural wellness industry and further strengthens the Company???s international presence (CNW Group|Canopy Growth Corporation)"' STYLE="height: 119px; width: 400px"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">London-based This Works will be an integral
part of Canopy Growth&rsquo;s entry into the natural wellness industry and further strengthens the Company&rsquo;s international
presence (CNW Group/Canopy Growth Corporation)</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Headquartered in London, England, This Works
offers a range of high-quality natural skincare and sleep solution products that have rewarded the company with a loyal following
of customers purchasing their best-known products including deep sleep pillow spray, morning expert hyaluronic serum, and skin
deep dry leg oil.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Through their unique approach of formulating
solutions that work in harmony with the 24hr body clock, This Works has evolved its product lines beyond a traditional viewpoint
to a more complete regimen that maximizes skin &ndash; and overall wellness &ndash; at every phase of the day, starting with a
good night's sleep. This acquisition is a key aspect of a multi-faceted hemp and CBD strategy as Canopy Growth continues to build
upon its vertically-integrated production and marketing platform, that currently includes thousands of acres of hemp production
across several continents, hundreds of millions of dollars of capital investment into hemp-derived CBD production and processing,
rapid expansion across the European Union and other key regions, and the introduction of new CBD-infused products and brands to
the global beauty, wellness, and sleep solution space.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">This Works CEO, Dr. Anna Persaud, will remain
at the helm of business operations post-acquisition to continue moving the company forward. Since joining the company in 2009,
Dr. Persaud has worked arduously to develop targeted skin solutions, which combine the brand's knowledge of the body clock with
modern lifestyle learnings, all backed by science. This approach to product development is best evidenced by This Works' award-winning
natural sleep solutions, with 4.2 million pillow sprays sold across Europe, the United Kingdom, China and the United States since
the brand's first deep sleep pillow spray launched in 2011. Together, Canopy Growth and This Works will continue to support all
of This Works' current operations with an accelerated focus on global expansion and product development to include a new line of
skincare and sleep solution products infused with CBD.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;Since 2004, This Works has been committed
to creating highly effective, natural skin solutions which are rooted in science and proven to work. We are excited about this
new chapter in our company's history and the opportunity to join Canopy Growth, the world's leading diversified cannabis and hemp
company,&quot; shared Dr. Anna Persaud. &quot;As a leading wellness brand and a pioneer in sleep beauty products, we are passionate
about the opportunity CBD offers beauty consumers. Canopy Growth will provide the expertise, research, scientific rigour and quality
assurance that will allow This Works to drive the agenda in wellness beauty's ever-evolving market.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;We were struck by how loyal and satisfied
the This Works customer base is, which is a testament to the integrity rooted in the company and how confidently they can stand
behind their name,&quot; said Bruce Linton, Chairman &amp; Co-CEO, Canopy Growth. &quot;We believe CBD has the potential to disrupt
the cosmetic and sleep solution industries and have been working for years to build and establish the right entry point into this
opportunity. As soon as we met with Dr. Persaud and her team, we knew they were the right partner to embark with on this journey.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">In addition to strengthening Canopy Growth's
product offering, bringing This Works &quot;under the canopy&quot; will enhance the Company's international footprint and operations
within the United Kingdom. In January 2019, the Company announced Spectrum Biomedical UK, a joint venture between Canopy Growth
Corporation and Oxford-based research company Beckley Canopy Therapeutics to address the need for high-quality cannabis-based medicinal
products in the UK.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Here's to Future (Cosmetics, Sleep, and overall
Wellness) Growth.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Canopy Growth Corporation</B><BR>
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct
brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through the Company's
subsidiary, Storz &amp; Bickel GMbH &amp; Co. KG. From product and process innovation to market execution, Canopy Growth is driven
by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
The Company has operations in over a dozen countries across five continents.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Company's medical division, Spectrum Therapeutics
is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding
of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics
sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol
under the brand Bionorica Ethics.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Company operates retail stores across Canada
under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and
loyal following by focusing on quality products and meaningful customer relationships.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">From our historic public listing on the Toronto
Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through
leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including
cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation
Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 4.4 million square feet of production
capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Notice Regarding Forward Looking Statements</B><BR>
This news release contains &quot;forward-looking statements&quot; within the meaning of the United States Private Securities Litigation
Reform Act of 1995 and &quot;forward-looking information&quot; within the meaning of applicable Canadian securities legislation.
Often, but not always, forward-looking statements and information can be identified by the use of words such as &quot;plans&quot;,
&quot;expects&quot; or &quot;does not expect&quot;, &quot;is expected&quot;, &quot;estimates&quot;, &quot;intends&quot;, &quot;anticipates&quot;
or &quot;does not anticipate&quot;, or &quot;believes&quot;, or variations of such words and phrases or state that certain actions,
events or results &quot;may&quot;, &quot;could&quot;, &quot;would&quot;, &quot;might&quot; or &quot;will&quot; be taken, occur
or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which
may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from
any future results, performance or achievements expressed or implied by the forward-looking statements or information contained
in this news release. Examples of such statements include statements such as &quot;This acquisition is a key aspect of a multi-faceted
hemp and CBD strategy as Canopy Growth continues to build upon its vertically-integrated production and marketing platform, that
currently includes thousands of acres of hemp production across several continents, hundreds of millions of dollars of capital
investment into hemp-derived CBD production and processing, rapid expansion across the European Union and other key regions, and
the introduction of new CBD-infused products and brands to the global beauty, wellness, and sleep solution space&quot;. Risks,
uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects
and opportunities to differ materially from those expressed or implied by such forward-looking information, including the Company's
ability to satisfy provincial sales contracts or provinces purchasing all cannabis allocated to them, and such risks contained
in the Company's annual information form dated June 27, 2018 and filed with Canadian securities regulators available on the Company's
issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the
forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed
on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking
information and forward-looking statements included in this news release are made as of the date of this news release and the Company
does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect
new information, subsequent events or otherwise unless required by applicable securities laws.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-acquires-established-skincare-and-well-being-company-this-works-300855013.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Canopy Growth Corporation</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:
http://www.newswire.ca/en/releases/archive/May2019/22/c0474.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001737927</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>Caitlin O'Hara, Media Relations,
Caitlin.Ohara@canopygrowth.com, 613-291-3239; Investor Relations, Tyler Burns, Tyler.Burns@canopygrowth.com, 855-558-9333 ext.
122; Director: Bruce Linton, tmx@canopygrowth.com</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Canopy Growth Corporation</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 07:00e 22-MAY-19</P>



<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></p>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !! &,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ I*
M6JNHSRVUA-+#'YCHI(7.,TF[*X(K7FNVEI \@<R!>"$&2I[9'6N(.M7]_P"<
MD<\NXLTAPWRXQT]@*H73W\CJ)$E +95<=3G(R/6EMTD"2,72# *NYR#UY&!^
M%>74KRF^QUPIJ*-JS\77NG%([Q?/0 8 /)_X%716/BRPOYXXH_,5GX^8=#[U
MYY).;LL]Q(Q=$^7WIUM#-L>:!B"AY&<'Z4H8FI%VW02I19ZY2UQ&F>*IK9EC
MO&#*IV,H&<<]0WIS[]*[2.1945T8,K#((.0:]*G5C45T<TH..X^BBBM"0HHH
MH 2H9S<;A]G$1&.=Y(_D*YW0I%U+2++4KV^EBO3,6F42D!7!(,)7I@=,>V:6
MQU.=]>GCNGD%KJ5N9;0.P &S@A<'NI5OSH W<W_]VV_[Z;_"LO4M,UB_D5XK
MR&WV-E0A;!^M9.GW5U!-IMC>7$]P9";BRG\P_OUV,6B<CJ5..O48]#3[6\N#
MH^@Z@ES+)?7ES&EPA8D.&)\Q=O0;1GZ;:F45)68T[%L>'-0\QW:Y@W2+\[#<
M3NR>1GIUJA)X*U&12/MEH >,B,]*ET>UO=0FEV74ZVL=[=13.;@DO'EE55'8
M@X(/;'O5SPNEQ.9#>7#R2:<[V61(2)2IR9&'J01].:S="#W12J211A\$W$49
M_P!(@+F,KG!QD]\?THG\%W=QY:O<6J(@P2B,&<>YIUO?B33$U#4)+LW9U'R&
M2&7;Y)\W:B%<XVXVY]<YJ)+NXBUR4"YF2$:R(/,,I8!3&I\O:>Q)Z]LT?5Z>
MU@]I+N6(O"-Q%;>4ILPQ&&E ?<?3'85J:1IVH:59BW#VTB@Y!^88K%%[='PT
MNJ^=+_:OVWR_*WG&?.V>5M]-OX]ZK7MY<:7=W,+7%PRZ;>K>RLTK'-HX'RGG
MD EL#_8JHTH1=TA.3>YV0-_D96VQWP6_PJU7(:K:RVN@_P!H?;;M)))(R$\]
MMJAYE]_[IVU9N8I;#Q'I-O!-/.KQW+&.2<C(!4KGUV[B!6A)T]%<SX:@6\T.
M.:ZFF>4RS DW#'I*P SGL !^%% &Z=/LS,\IM8/,D!#OY8RP/!R>]0W%I K1
M!=,CF$:X0A4&P>@ST_"K]% &8\PL[="NE.(X>45/+^3Z#/'4]/6LU]?LK1_M
M+:/<QR2'&X1IO8GKWSGBNBDC26-DD4,C#!5AD&J(T2R6=YO*#2,.-_.WC&!Z
M"HGS_9*5NIB6WC'2K=3]FTVXB1F^8I$B@M[X/6E@\7Z9 ':WTVYC$A+,R1(H
M8CJ>O-3/HT5C#96(VE;F?$Q"XW  MC_QT#Z5J:GI]M/ITZM!&<(6&%'! .*Q
M3JV>J*]PPSXKTF61;G^RYWD)X?R4+9'?KGBDC\4Z-("%TF7;,^6)@0!F'.2<
M]:O:)HEB-$BDCA#// "6DY(++S^%,_LB&TDTW3_E:.1F>7Y0-Y4;A^O\J+U;
M)Z![A OBK3&G%P-+N?-9=XD,* D=,YS^%:%KJT6I.XCTN=O,3:Y=$P0/X3S[
MGBM"?3[:Y51)"F5.X$#D&I8+>.VCV0J%7).!ZFM8J=]62[6T*LO^E*L5QIAD
MCR.)-C >^,U9:TMVE25H(C(@VJY094>@/:IJ*T)*JZ78J,+96P'H(E_PHJU1
M0 4444 %(QP"<@<=32U6O[,7UMY3-@;E;'4-@YP1W'% %6;39[DPR/>DR0N9
M(R(P!G! ^HYIBZ=J+B43ZH2) 1M2%0 .G%59Y=2TK>\<7F1;V.W&549R, <C
M #=>Y J=/$* N)K:1=@<[E.5(3[^#QTJ.1#N/M]+O;.WBAM]1_=Q($ >$'('
M3O3SIMS*]M-/>YG@W$%8@%R1@\4P>(K5HGD"R!5D$9)  !.0"?0<5 VIW]PR
MK%;!5+LCB-LLI5@&&2,9QR/7%'(@NS8A+*-DLJO(.3@8..W%2UE:9IDUO+]H
MN)Y#*R_,H8E23UX/3UX]36K5B"BBB@ HHHH **** "BBB@!.]8.N?\>MO_UV
I-%% &'#_ ,?=W_USG_\ 0Y*[6#_5GZT44 2BEHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[0*H4&AO=&]S:&]P(#,N,  X0DE-! 0
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M;VXM0V%N;W!Y($=R;W=T:"!A8W%U:7)E<R!E<W1A8FQI<VAE9"!S:VD< @4
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M+@",VD'(C-2KK6TEMME3<:^HCIJ2DA?-43RNTLBC:TN<YQ]@ !)/X(#O14^
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21$ 1$0!$1 $1$ 1$0!$1 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
